脳血管内科・SCU
研究業績
  1. Yamaguchi E, Yoshimoto T, Ogura S, Saito K, Saito S, Hattori Y, Wasida K, Nishimura K, Toyoda K, Koga M, Ihara M. Association of the RNF213 p.R4810K Variant With the Outer Diameter of Cervical Arteries in Patients With Ischemic Stroke. Stroke: Vascular and Interventional Neurology. 2, e000298, 2022.
  2. Yoshimoto T, Tanaka K, Koge J, Saito S, Yamagami H, Nakaoku Y, Ogata S, Nishimura K, Yamaguchi E, Chiba T, Kawakami D, Shiozawa M, Kamogawa N, Ohta T, Satow T, Inoue M, Hattori Y, Washida K, Kataoka H, Chung JW, Bang OY, Toyoda K, Koga M, Maruyama H, Ihara M. Impact of the RNF213 p.R4810K Variant on Endovascular Therapy for Large‐Vessel Occlusion Stroke. Stroke: Vascular and Interventional Neurology. 2, e000396, 2022.
  3. Koge J, Tanaka K, Yoshimoto T, Shiozawa M, Ohta T, Satow T, Kataoka H, Ihara M, Koga M, Toyoda K. Mechanical Thrombectomy Beyond 2b Reperfusion: Should We Pursue a Higher Reperfusion Grade after Achievement of 2b? Stroke: Vascular and Interventional Neurology. 2, e000196, 2022.
  4. Kamogawa N, Tanaka K, Yamagami H, Yoshimoto T, Uchida K, Morimoto T, Imamura H, Sakai N, Ohara N, Matsumoto Y, Takeuchi M, Shigeta K, Toyoda K, Yoshimura S. Outcomes of Symptomatic Anterior Large Vessel Occlusion by Initial Imaging Assessment Using Diffusion‐Weighted Imaging Versus Noncontrast Computed Tomography. Stroke: Vascular and Interventional Neurology. 2, e000170, 2022.
  5. Abe S, Tanaka T, Fukuma K, Matsubara S, Motoyama R, Mizobuchi M, Yoshimura H, Matsuki T, Manabe Y, Suzuki J, Ishiyama H, Tojima M, Kobayashi K, Shimotake A, Nishimura K, Koga M, Toyoda K, Murayama S, Matsumoto R, Takahashi R, Ikeda A, Ihara M; PROPOSE Study Investigators. Interictal epileptiform discharges as a predictive biomarker for recurrence of poststroke epilepsy. Brain Communications. 4, fcac312, 2022.
  6. Okumura K, Yamashita T, Akao M, Atarashi H, Ikeda T, Koretsune Y, Shimizu W, Suzuki S, Tsutsui H, Toyoda K, Hirayama A, Yasaka M, Yamaguchi T, Teramukai S, Kimura T, Morishima Y, Takita A, Inoue H. Oral Anticoagulants in Very Elderly Nonvalvular Atrial Fibrillation Patients With High Bleeding Risks: ANAFIE Registry. JACC: Asia. 2, 720-733, 2022.
  7. Fischer U, Trelle S, Branca M, Salanti G, Paciaroni M, Ferrari C, Abend S, Beyeler S, Strbian D, Thomalla G, Ntaios G, Bonati LH, Michel P, Nedeltchev K, Gattringer T, Sandset EC, Kelly P, Lemmens R, Koga M, Sylaja PN, de Sousa DA, Bornstein NM, Gdovinova Z, Seiffge DJ, Gralla J, Horvath T, Dawson J. Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial. European Stroke Journal. 7, 487-495, 2022.
  8. Egashira S, Yoshimoto T, Koge J, Ihara M. Late-onset cerebral embolism after transcatheter aortic valve implantation under direct oral anticoagulant therapy. Journal of Stroke and Cerebrovascular Diseases. 31, 106525, 2022.
  9. Egashira S, Koga M, Toyoda K. Intravenous Thrombolysis for Acute Ischemic Stroke in Patients with End-Stage Renal Disease on Hemodialysis: A Narrative Review. Journal of Cardiovascular Development and Disease. 9, 446, 2022.
  10. Miwa K, Toyoda K. Covert vascular brain injury in chronic kidney disease. Frontiers in Neurology. 13, 824503, 2022.
  11. Koge J, Yamagami H, Toyoda K, Yasaka M, Hirano T, Hamasaki T, Nagao T, Yoshimura S, Fujishige M, Tempaku A, Uchiyama S, Mori E, Koga M, Minematsu K. Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation. PLOS ONE. 17, e0264760, 2022.
  12. Toyoda K, Yoshimura S, Fukuda-Doi M, Qureshi AI, Martin RH, Palesch YY, Ihara M, Suarez JI, Okada Y, Hsu CY, Itabashi R, Wang Y, Yamagami H, Steiner T, Sakai N, Yoon BW, Inoue M, Minematsu K, Yamamoto H, Koga M; ATACH Trial Investigators and the SAMURAI Investigators. Intensive blood pressure lowering with nicardipine and outcomes after intracerebral hemorrhage: An individual participant data systematic review. International Journal of Stroke. 17, 494-505, 2022.
  13. Miyamoto S, Ogasawara K, Kuroda S, Itabashi R, Toyoda K, Itoh Y, Iguchi Y, Shiokawa Y, Takagi Y, Ohtsuki T, Kinouchi H, Okada Y, Takahashi JC, Nakase H, Kakuda W; Committee for Stroke Guideline 2021, the Japan Stroke Society. Japan Stroke Society Guideline 2021 for the Treatment of Stroke. International Journal of Stroke. 17, 1039-1049, 2022.
  14. Kodani E, Tomita H, Nakai M, Akao M, Suzuki S, Hayashi K, Sawano M, Goya M, Yamashita T, Fukuda K, Ogawa H, Tsuda T, Isobe M, Toyoda K, Miyamoto Y, Miyata H, Okamura T, Sasahara Y, Okumura K; J-RISK AF Research Group. Impact of baseline blood pressure on adverse outcomes in Japanese patients with non-valvular atrial fibrillation: the J-RISK AF. European Heart Journal Open. 2, oeac081, 2022.
  15. Kim JS, Thijs V, Yudi M, Toyoda K, Shiozawa M, Zening J, Clapp B, Albers B, Diener HC. Establishment of the Heart and Brain Team for Patent Foramen Ovale Closure in Stroke Patients: An Expert Opinion. Journal of Stroke. 24, 345-351, 2022.
  16. Nguyen TN, Qureshi MM, Klein P, Yamagami H, Abdalkader M, Mikulik R, Sathya A, Mansour OY, Czlonkowska A, Lo H, Field TS, Charidimou A, Banerjee S, Yaghi S, Siegler JE, Sedova P, Kwan J, de Sousa DA, Demeestere J, Inoa V, Omran SS, Zhang L, Michel P, Strambo D, Marto JP, Nogueira RG; SVIN COVID-19 Global COVID Stroke Registry, Kristoffersen ES, Tsivgoulis G, Lereis VP, Ma A, Enzinger C, Gattringer T, Rahman A, Bonnet T, Ligot N, De Raedt S, Lemmens R, Vanacker P, Vandervorst F, Conforto AB, Hidalgo RCT, Mora Cuervo DL, de Oliveira Neves L, Lameirinhas da Silva I, Martíns RT, Rebello LC, Santiago IB, Sakelarova T, Kalpachki R, Alexiev F, Cora EA, Kelly ME, Peeling L, Pikula A, Chen HS, Chen Y, Yang S, Roje Bedekovic M, Čabal M, Tenora D, Fibrich P, Dušek P, Hlaváčová H, Hrabanovska E, Jurák L, Kadlčíková J, Karpowicz I, Klečka L, Kovář M, Neumann J, Paloušková H, Reiser M, Rohan V, Šimůnek L, Skoda O, Škorňa M, Šrámek M, Drenck N, Sobh K, Lesaine E, Sabben C, Reiner P, Rouanet F, Strbian D, Boskamp S, Mbroh J, Nagel S, Rosenkranz M, Poli S, Thomalla G, Karapanayiotides T, Koutroulou I, Kargiotis O, Palaiodimou L, Barrientos Guerra JD, Huded V, Nagendra S, Prajapati C, Sylaja PN, Sani AF, Ghoreishi A, Farhoudi M, Sadeghi Hokmabadi E, Hashemilar M, Sabetay SI, Rahal F, Acampa M, Adami A, Longoni M, Ornello R, Renieri L, Romoli M, Sacco S, Salmaggi A, Sangalli D, Zini A, Sakai K, Fukuda H, Fujita K, Imamura H, Kosuke M, Sakaguchi M, Sonoda K, Matsumaru Y, Ohara N, Shindo S, Takenobu Y, Yoshimoto T, Toyoda K, Uwatoko T, Sakai N, Yamamoto N, Yamamoto R, Yazawa Y, Sugiura Y, Baek JH, Lee SB, Seo KD, Sohn SI, Lee JS, Arsovska AA, Chieh CY, Wan Zaidi WA, Wan Yahya WNN, Gongora-Rivera F, Martinez-Marino M, Infante-Valenzuela A, Dippel D, van Dam-Nolen DHK, Wu TY, Punter M, Adebayo TT, Bello AH, Sunmonu TA, Wahab KW, Sundseth A, Al Hashmi AM, Ahmad S, Rashid U, Rodriguez-Kadota L, Vences MÁ, Yalung PM, Dy JSH, Brola W, Dębiec A, Dorobek M, Karlinski MA, Labuz-Roszak BM, Lasek-Bal A, Sienkiewicz-Jarosz H, Staszewski J, Sobolewski P, Wiącek M, Zielinska-Turek J, Araújo AP, Rocha M, Castro P, Ferreira P, Nunes AP, Fonseca L, Pinho E Melo T, Rodrigues M, Silva ML, Ciopleias B, Dimitriade A, Falup-Pecurariu C, Hamid MA, Venketasubramanian N, Krastev G, Haring J, Ayo-Martin O, Hernandez-Fernandez F, Blasco J, Rodríguez-Vázquez A, Cruz-Culebras A, Moniche F, Montaner J, Perez-Sanchez S, García Sánchez MJ, Guillán Rodríguez M, Bernava G, Bolognese M, Carrera E, Churojana A, Aykac O, Özdemir AÖ, Bajrami A, Senadim S, Hussain SI, John S, Krishnan K, Lenthall R, Asif KS, Below K, Biller J, Chen M, Chebl A, Colasurdo M, Czap A, de Havenon AH, Dharmadhikari S, Eskey CJ, Farooqui M, Feske SK, Goyal N, Grimmett KB, Guzik AK, Haussen DC, Hovingh M, Jillela D, Kan PT, Khatri R, Khoury NN, Kiley NL, Kolikonda MK, Lara S, Li G, Linfante I, Loochtan AI, Lopez CD, Lycan S, Male SS, Nahab F, Maali L, Masoud HE, Min J, Orgeta-Gutierrez S, Mohamed GA, Mohammaden M, Nalleballe K, Radaideh Y, Ramakrishnan P, Rayo-Taranto B, Rojas-Soto DM, Ruland S, Simpkins AN, Sheth SA, Starosciak AK, Tarlov NE, Taylor RA, Voetsch B, Zhang L, Duong HQ, Dao VP, Le HV, Pham TN, Ton MD, Tran AD, Zaidat OO, Machi P, Dirren E, Rodríguez Fernández C, Escartín López J, Fernández Ferro JC, Mohammadzadeh N, Suryadevara NC, de la Cruz Fernández B, Bessa F, Jancar N, Brady M, Scozzari D. Global Impact of the COVID-19 Pandemic on Cerebral Venous Thrombosis and Mortality. Journal of Stroke. 24, 256-265, 2022.
  17. Toyoda K, Koga M; as the SAMURAI Investigators. Controlling blood pressure soon after intracerebral hemorrhage: The SAMURAI-ICH Study and its successors. Hypertension Research. 45, 583-590, 2022.
  18. Toyoda K. Intensive blood pressure lowering for ischemic stroke patients: does it prevent ischemia or bleeding? Hypertension Research. 45, 769-771, 2022.
  19. Ohya Y, Kario K, Itoh H, Nishiyama A, Ishimitsu T, Ichihara A, Kai H, Kashihara N, Katsuya T, Miura K, Mukoyama M, Nakamura S, Node K, Ohishi M, Saito S, Shibata H, Shimosawa T, Tamura K, Toyoda K, Ali MAM, Chia YC, Constantine G, Erwinanto E, Ihm SH, Kao HL, Van Minh H, Narasingan SN, Ona DID, Siddique S, Sukonthasarn A, Teo BW, Unurjargal T, Wang JG, Wang TD, Raukgi H. Statement of the Asian Hypertension Society Network: the Okinawa Declaration on the unity of hypertension societies in Asian countries and regions to overcome hypertension and hypertension-related diseases. Hypertension Research. 45, 1-2, 2022.
  20. Yoon BW, Lee JT, Chang KC, Toyoda K, Jeng JS, Venketasubramanian N. Asia Pacific Stroke Conference 2022: Stroke Care Reform through Collaboration and Cooperation. Cerebrovascular Diseases. 51, III-IV, 2022.
  21. Arafa A, Kokubo Y, Sheerah HA, Sakai Y, Watanabe E, Li J, Honda-Kohmo K, Teramoto M, Kashima R, Nakao YM, Koga M. Developing a Stroke Risk Prediction Model Using Cardiovascular Risk Factors: The Suita Study. Cerebrovascular Diseases. 51, 323-330, 2022.
  22. Uchida K, Shindo S, Yoshimura S, Toyoda K, Sakai N, Yamagami H, Matsumaru Y, Matsumoto Y, Kimura K, Ishikura R, Yoshida A, Inoue M, Beppu M, Sakakibara F, Shirakawa M, Morimoto T; RESCUE-Japan LIMIT Investigators. Association Between Alberta Stroke Program Early Computed Tomography Score and Efficacy and Safety Outcomes With Endovascular Therapy in Patients With Stroke From Large-Vessel Occlusion: A Secondary Analysis of the Recovery by Endovascular Salvage for Cerebral Ultra-acute Embolism-Japan Large Ischemic Core Trial (RESCUE-Japan LIMIT). JAMA Neurology. 79, 1260-1266, 2022.
  23. SVIN COVID-19 Global SAH Registry. Global impact of the COVID-19 pandemic on subarachnoid haemorrhage hospitalisations, aneurysm treatment and in-hospital mortality: 1-year follow-up. Journal of Neurology, Neurosurgery & Psychiatry. 93, 1028-1038, 2022.
  24. 井上 学. 一過性脳虚血発作　画像診断. 日本臨床 増刊号2 最新臨床脳卒中学（第2版）下. 80, 237-241, 2022.
  25. 井上 学. 脳梗塞画像診断の最新動向. 医学のあゆみ. 280, 992-999, 2022.
  26. 井上 学. 灌流画像ソフトRAPIDを活用する急性虚血性脳卒中治療. Rad fan. 20, 73-76, 2022.
  27. 岡田 敬史, 古賀 政利. ASPECTS. 日本臨床 増刊号1 最新臨床脳卒中学（第2版）上. 80, 465-468, 2022.
  28. 鴨川 徳彦, 豊田 一則. 抗血小板療法の最新動向. 医学のあゆみ. 280, 1070-1076, 2022.
  29. 菊野 宗明, 田中 寛大, 畠山 金太, 古賀 政利. 脳血管撮影前の超音波検査による全身血管評価の重要性が示唆されたコレステロール塞栓症の1例. Neurosonology. 35, 39-41, 2022.
  30. 吉村 壮平, 豊田 一則. 脳卒中. 日常生活に活かす診療ガイドラインUP-TO-DATE 2022-2023. 556-564, 2022.
  31. 吉本 武史, 豊田 一則. 脳血管障害update. Brain and NERVE. 74, 853-859, 2022.
  32. 宮本 享, 位田 隆一, 井林 雪郎, 小笠原 邦昭, 片岡 大治, 古賀 政利, 塩川 芳昭, 竹川 英宏, 中島 弘, 橋本 洋一郎, 藤井 由記代, 藤本 茂, 藥師寺 祐介, 一般社団法人日本脳卒中学会, 脳卒中における緩和と療養の生命倫理に関するプロジェクトチーム. 自宅復帰困難な後遺症を呈する脳卒中の維持期(生活期)における緩和と療養に関する提言. 脳卒中. 44, 671-679, 2022.
  33. 江頭 柊平, 吉本 武史, 田中 寛大, 鴨川 徳彦, 塩澤 真之, 髙下 純平, 豊田 一則, 古賀 政利. バセドウ病，IgG4関連眼疾患を有しCOVID-19回復後に一過性脳虚血発作を呈した脳静脈洞血栓症：症例報告. 臨床神経. 62, 928-934, 2022.
  34. 黒田 健仁, 豊田 一則. 脳血管疾患・認知症と血圧管理. カレントテラピー. 40, 884-889, 2022.
  35. 三輪 佳織, 八木田 佳樹. 臨床医のための神経病理　再入門　Fabry病. Clinical Neuroscience. 40, 920-922, 2022.
  36. 山口 枝里子, 豊田 一則. 経静脈的血栓溶解療法の現状と今後の課題. カレントテラピー. 40, 228-232, 2022.
  37. 石上 晃子, 豊田 一則. 血栓溶解薬. Pocket Drugs. 118-121, 2022.
  38. 入江 研一, 三輪 佳織, 池之内 初, 千葉 哲矢, 細木 聡, 吉村 壮平, 猪原 匡史, 豊田 一則, 古賀 政利. 頭蓋内椎骨動脈解離における延髄梗塞の特徴と機能的転帰. 脳卒中. 44, 512-517, 2022.
  39. 豊田 一則. CSPS.com. 日本臨床 増刊号2 最新臨床脳卒中学（第2版）下. 80, 536-541, 2022.
  40. 豊田 一則. ブレインハートチーム診療. Medical Practice. 39, 1411, 2022.
  41. 豊田 一則. THAWS試験 ― 発症時刻不明脳梗塞患者へのMRIミスマッチ診断を用いた静注血栓溶解療法. 神経治療学. 39, 367-372, 2022.
  42. 豊田 一則. 感染症と脳血管障害：感染性心内膜炎と新型コロナウイルス感染症. Neuroinfection. 27, 75-79, 2022.
  43. 豊田 一則. 脳卒中医学の臨床試験：国民病制圧への弛まぬ挑戦. 医療の広場. 62, 4-7, 2022.
  44. 豊田 一則, 吉村 壮平. 日本脳卒中データバンク. 日本臨床 増刊号1 最新臨床脳卒中学（第2版）上. 80, 76-80, 2022.
  45. 豊田 一則, 吉村 壮平. 過去20年の脳卒中患者の治療転帰の推移：日本脳卒中データバンク. 循環器病研究の進歩. 43, 47-53, 2022.
  46. 鈴木 文昭, 古賀 政利. THAWS試験. 日本臨床 増刊号2 最新臨床脳卒中学（第2版）下. 80, 531-535, 2022.
  47. 宮田 敏行, 和田 晋一. 血液凝固因子・凝固制御因子. 日本臨床 増刊号2 最新臨床脳卒中学（第2版）下. 80, 673-678, 2022.
  48. 宮田 敏行. 第67回Scientific Standardization Committee 学術報告、Genomics in Thrombosis and Hemostasis. 2021年度国際血栓止血学会SSC報告書. 99-112, 2022.
  49. 宮田 敏行, 川原 幸一. 補体経路と凝固線溶系. Thrombosis Medicine. 12, 232-238, 2022.
  50. 宮田 敏行. 補体の多面性：凝固・線溶系、キニンと補体. 日本臨床. 80, 1735-1740, 2022.